Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-one research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and fifteen have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $611.86.
Several brokerages have recently commented on ISRG. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Truist Financial reduced their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research report on Monday, March 17th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Finally, CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock.
Read Our Latest Report on ISRG
Intuitive Surgical Trading Down 0.7 %
Insider Activity
In other news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Intuitive Surgical
Several institutional investors and hedge funds have recently modified their holdings of ISRG. Howard Capital Management Group LLC raised its stake in Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares during the last quarter. Principal Financial Group Inc. lifted its stake in shares of Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after purchasing an additional 9,194 shares during the period. Arete Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $525,000. Soltis Investment Advisors LLC lifted its position in Intuitive Surgical by 12.6% during the third quarter. Soltis Investment Advisors LLC now owns 519 shares of the medical equipment provider’s stock valued at $255,000 after purchasing an additional 58 shares in the last quarter. Finally, M&T Bank Corp increased its holdings in Intuitive Surgical by 0.3% in the 3rd quarter. M&T Bank Corp now owns 68,581 shares of the medical equipment provider’s stock worth $33,691,000 after acquiring an additional 226 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Best Stocks Under $5.00
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- Golden Cross Stocks: Pattern, Examples and Charts
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- What is a support level?
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.